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To the Editor—Staphylococcus aureus
ST398 is a zoonotic agent primarily de-
scribed in Europe that is becoming
a worldwide threat associated with live-
stock, their human contacts, and food
products. In animals, carriage is fre-
quent, but infections are rare. In hu-
mans, infections consist in nosocomial
bloodstream and wound infections [1]
that are associated with spa types 011 or
034, tetracycline resistance, and the
absence of panton-valentine leukocidin
(PVL). Recently, a new population of
ST398 strains has been isolated in China
and from children adopted from China
[2] that is responsible for pneumonia
and skin and soft-tissue infections in
patients without association with ani-
mals or animal farming and which is
characterized by spa type 571, tetracy-
cline susceptibility, and variable pres-
ence of PVL [3].
Annual surveys of bloodstream infec-
tion are performed in the center region of
France [4, 5]. In 2009, we observed the
emergence of cases associated with t571,
TetS, and PVL-negative ST398 strains.
Examination of patient histories revealed
exposure to animals in 1 case, a fatal id-
iopathic community-acquired blood-
stream infection in an 84-year-old man
who lived on a farm at which 1 pig was
being raised. The remaining cases were
hospital-acquired and included 1 case of
catheter-associated infection observed in
a 58-year-old man with advanced multi-
ple myeloma, 1 case following elective
digestive tract surgery in a 69-year-old
woman, and 1 case following cardiac
surgery in a 68-year-old man.
Microarray and MLVA analysis [7]
were performed to characterize the
strains and compare them with Euro-
pean pig-borne methicillin-resistant S.
aureus and virulent strains (USA300,
MW2, TW20, COL, and Newman).
Most characteristics of the present
strains were similar to those of the
pig-borne strain. All were of accessory
gene regulation type I, and none
contained the genes encoding the
following virulence factors: EsxA and
EsxB proteins; leukocidin F; Panton-
Valentine Leukocidin; TSST-1; ex-
foliatins A and B; and enterotoxins
A–E, G–R, and U. None harbored the
lantibiotic epidermin/gallidermin genes
epiA–epiF typically reported in virulent
strains. In addition, similarly to the
pig-borne strain, our strains harbored
the cna gene, encoding a collagen
adhesin associated with colonizing
strains and involved in the pathogenesis
of osteomyelitis and infectious arthritis
[6]; the hyaluronidase gene, involved in
the early stages of subcutaneous
infections; and a factor SAV2371, as-
sociated with bacterial attachment to
host cells and virulence. By contrast,
unlike the pig-borne strain, the studied
strains and the USA300 virulent clone
shared cadC–cadM genes, which are
responsible for cadmium resistance,
and prophagic genes. In addition, the
strains harbored remnants of staphylo-
coccal cassette chromosome mec (IS1272
and Tn554), similar to the strains re-
ported from China [2]. Importantly, the
strains appeared to be deficient in
the type I restriction system (hsdS–hsdR),
the main function of which is to limit
horizontal gene transfer [8, 9].
Our observations show the emergence
of new ST398 strains in human in-
fectious diseases that differ from pig-
borne strains and share similarity with
Chinese-type and USA300 strains. The
similarity with the USA300 virulent
clone highlights their high potential for
virulence and alerts us about the need to
develop an active surveillance strategy to
study and control the rapid spread of
this clone. Transmission of pig-borne
ST398 between animals and humans, as
well as between humans, has been de-
scribed [10, 11]. In the present cases of
bloodstream infection, which were
identified at 4 unrelated health care in-
stitutions, our data do not clarify how
the strains were transmitted, which
highlights the need for further epidemi-
ological studies.
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